Markets
U.S. open in 31 hrs, 31 mins
BUSINESS NEWS
- Market News
- Earnings
- Recalls
- Recession Watch
- Tech News
- Financial Crisis
- Madoff Scandal
- BloggingStocks
- Luxist
- Money Videos
INVESTING
- Stock Quotes
- Stock Charts
- Stock Ticker
- Currencies
- Portfolio
- Stock Screener
- Broker Center
- Mutual Fund Center
- ETF Center
- Money
- 24/7 Wall St.
- Financial Glossary
PERSONAL FINANCE AT WALLETPOP
- Bargains
- Banking
- Budget
- Calculators
- College Finance
- Community
- Credit
- Deals
- Debt
- Economizer
- Food
- Home
- Fraud
- Insurance
- Interest Rates
- Loans
- Mortgages
- Real Estate
- Recalls
- Recession
- Retirement
- Saving
- Simplification
- Specials
- Taxes
SMALL BUSINESS
Biotech Showcase™ Partners with Astia to Help Women Biotech Entrepreneurs Successfully Grow Their Businesses
Business Wire
EBD Group and Demy-Colton Life Science Advisors, the producers of
Biotech Showcase™, and Astia today announced a strategic collaboration
designed to ensure that women-led biotech companies gain the investor
and industry relationships needed to successfully grow their businesses.
Under this agreement, Astia’s biotech clients participating in the Astia
Silicon Valley Doing it Right Program will have the opportunity to
present at the second annual Biotech Showcase 2010 held on January
12–13, 2010 at the Marines’ Memorial Club and Hotel, San Francisco, CA.
Astia is a global network of over 700 experts whose goal is to ensure
the success of women in high-growth start-ups, primarily in high tech,
clean tech and life science sectors. Co-produced by EBD Group and
Demy-Colton Life Science Advisors, the Biotech Showcase is a forum
providing private and public companies an opportunity to present to an
audience of investors and biopharmaceutical business development
executives.
“The Biotech Showcase has quickly established itself as a premier venue
for companies to present their innovations to potential private and
institutional investors and business development teams from
pharmaceutical and large biotech firms,” said Sharon Vosmek, CEO, Astia.
“Being featured at the Biotech Showcase has the potential to catapult a
company several steps forward toward achieving its business goals, and
this is why we view it as ‘the forum’ for the Astia companies to be
showcased.”
Astia's Silicon Valley Doing it Right program provides unprecedented
access to funding, markets and expertise resulting in an exceptional
success rate for its clients. Since 2003, greater than 60 per cent of
the companies who have presented at the Astia Investor Forums have
achieved funding or an exit within one year. During this same period, 12
companies have exited, including two IPS, both in the biotech space.
Chris Meda, president and CEO of Astia supported company, Arcxis
Biotechnologies, remarked, “As CEO of a biotech start up and an Astia
alumna I am excited about the announcement of the partnership with
Biotech Showcase – this will allow Astia entrepreneurs to benefit from
the power of the Astia community while ensuring we are being showcased
in one of the premier forums for our industry. Astia has always reached
out for the best opportunities for its entrepreneurs and this is another
illustration.”
“Astia is an organization we are excited to be working with,” said
Carola Schropp, President, EBD Group. “By working with exceptional women
entrepreneurs as they drive innovation and build successful biotech
companies, Astia plays an important role in the long-term success of our
bio-economy.”
“I am very excited about this opportunity to work with Astia. Building a
successful life science company takes great science, access to capital
and, above all, a great management team. We are very impressed with the
community that Astia offers up and coming management teams and the fact
that advisors are there for the long-term,” said Sara Jane Demy,
President of Demy-Colton Life Science Advisors.
About Astia
Astia is a global non-profit organization that provides innovative
programs to exceptional women-led start-ups. Head-quartered in San
Francisco, Astia delivers programs for entrepreneurs in Silicon Valley,
New York, London and, from 2010, India. Astia is well-positioned to work
with start-ups around the world as they access capital, grow their
businesses, and develop the leadership of the founding team. The Astia
model of engaging a community of experts to the benefit of the select
start-ups it serves has resulted in an exceptional success rate; since
2003, 60% of companies that have participated in the Astia Investor
Forums have secured funding or an exit within one year of presenting.
For more information:
www.astia.org.
About EBD Group
EBD Group is the leading partnering firm for the global life science
industry. Since 1993, biotech, pharma and medical device companies have
leveraged EBD Group’s partnering conferences, technology and services to
identify business opportunities and develop strategic relationships
essential to their success. EBD Group’s conferences are run with the
support of leading corporations and international trade associations,
and include:
- BIO-Europe and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for life science companies to present to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
EBD Group’s sophisticated web-based partnering service, partneringONE®,
is used as the partnering engine at numerous third-party events around
the world. Outside of the conference format, EBD Group’s consultants
provide hands-on assistance for firms seeking to in- or out-license
products and technologies.
EBD Group has offices in the USA and Europe.
For more information visit
www.ebdgroup.com
About Demy-Colton Life Science Advisors
Demy-Colton is a consulting company focused exclusively on facilitating
the growth of the life science industry. Sara Jane Demy, the principal
of Demy-Colton, is a leader at designing and developing high-value added
programs and services to address the business needs of the biotechnology
industry. Deep domain knowledge and twenty-years experience will be
applied to launching new industry programs and counseling local and
regional organizations that wish to increase the level of support and
services they provide their biotechnology constituents. Demy-Colton
programs include:
- Biotech Showcase™, co-developed with EBD Group, is a unique forum in San Francisco for life science companies to present to investors and business development executives
- The Life Sciences Summit, developed with the Center for Biotechnology is a translational science meeting with collaborations as the objective
- Partnering for Cures developed with FasterCures is the first meeting to bring together medical philanthropists with medical research foundations and the biopharmaceutical industry
- Biocom – CalAsia and Investor Conference (program development)
Demy-Colton Life Science Advisors has also developed Collaborate™, a
partnering system suitable for small partnering conferences.
Copyright Business Wire 2009
2009-10-12 10:25:00
COMMENTS ( 0 )
Latest Money News
CNNMoney
- Talk about a low interest rate: U.S. Treasury borrows $44 billion for less than 1%
- Google set to map the world - and push out GPS makers as a result?
- Washington Mutual gave a mortgage to O.J. Simpson
- Closing Bell: Economic Catapult for Thanksgiving & Black Friday (WMT, TGT, GRMN, GOOG, MSFT)
- Deere up on Q4 earnings performance